# Profiling 26S Proteasome Activity of Plasmodium falciparum Monitored by a Live-Cell Assay

**Authors:** Adriana F. Gonçalves, Ana Lima-Pinheiro, Belém Sampaio-Marques, Pedro E. Ferreira

PMC · DOI: 10.3390/ijms27052104 · International Journal of Molecular Sciences · 2026-02-24

## TL;DR

This study introduces a live-cell assay to measure proteasome activity in malaria parasites, which could help in developing new treatments.

## Contribution

A novel live-cell assay using GFP-DD and MitoTracker to monitor proteasome activity in Plasmodium falciparum.

## Key findings

- GFP-DD fluorescence increases with proteasome inhibition or stabilization, providing an inverse readout of activity.
- MG132 induces a dose-dependent increase in fluorescence, confirming its inhibitory effect on the proteasome.
- The assay offers a practical platform for studying the ubiquitin–proteasome system in live parasites.

## Abstract

Malaria remains a major global health challenge, driven in part by widespread antimalarial drug resistance in Plasmodium parasites. Artemisinin-based combination therapies (ACTs) are currently the first-line treatment; however, resistance has also emerged. Artemisinin damages parasite proteins, promoting their ubiquitination and subsequent proteasomal degradation. Because inhibitors of the Plasmodium 26S proteasome synergize with artemisinin, the proteasome has emerged as a promising drug target, yet tools to monitor its function in live parasites remain limited. Here, we generated a P. falciparum line expressing green fluorescent protein fused to a destabilization domain (GFP-DD) to assess proteasome activity and combined it with MitoTrackerTM staining. In the absence of the stabilizing ligand Shield-1, the GFP-DD reporter is rapidly degraded by the proteasome. Using fluorescence microscopy and flow cytometry, we show that GFP-DD fluorescence provides a quantitative, inverse readout of proteasomal activity, increasing upon ligand-mediated stabilization or pharmacological inhibition with MG132. Shield-1 titration identified an optimal stabilization range, and MG132 induced a dose-dependent fluorescence increase. This work establishes a practical live-cell platform to probe ubiquitin–proteasome system function, with potential applications in future phenotypic screening and antimalarial resistance studies.

## Linked entities

- **Proteins:** mg132 (methyltransferase type 11)
- **Chemicals:** MG132 (PubChem CID 462382), Shield-1 (PubChem CID 44455162)
- **Diseases:** malaria (MONDO:0005136)
- **Species:** Plasmodium falciparum (taxon 5833)

## Full-text entities

- **Diseases:** Malaria (MESH:D008288)
- **Chemicals:** MitoTrackerTM (-), MG132 (MESH:C072553), Artemisinin (MESH:C031327)
- **Species:** Plasmodium falciparum (malaria parasite P. falciparum, species) [taxon 5833]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12985172/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12985172/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12985172/full.md

---
Source: https://tomesphere.com/paper/PMC12985172